Neurotrophins regulate ApoER2 proteolysis through activation of the Trk signaling pathway

BMC Neuroscience

Volumn 15, Issue 1, 2014, Pages

  Larios, Jorge A ^a,b   Jausoro, Ignacio ^a   Benitez, Maria Luisa ^a   Bronfman, Francisca C ^a   Marzolo, Maria Paz ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

ApoER2; Neurotrophins; p75NTR; PC12 cells; Proteolytic processing; Reelin; Shedding; Trk

Indexed keywords

APOLIPOPROTEIN E RECEPTOR 2; APOLIPOPROTEIN E2; BRAIN DERIVED GROWTH FACTOR; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR P75; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE A; REELIN; UNCLASSIFIED DRUG; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 8; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR RECEPTOR; NERVE PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; TNFRSF16 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRACELLULAR SIGNALING; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PC12 CELL LINE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CELL CULTURE; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; CEREBRAL CORTEX; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; LDL-RECEPTOR RELATED PROTEINS; METALLOPROTEASES; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; RECEPTOR, TRKB; RECEPTORS, NERVE GROWTH FACTOR; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84908116725     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-15-108     Document Type: Article

References (102)

1. Marzolo MP, Bu G. Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin Cell Dev Biol 2009, 20(2):191-200. 10.1016/j.semcdb.2008.10.005, 2691858, 19041409.
2. Fortini ME. Notch signaling: the core pathway and its posttranslational regulation. Dev Cell 2009, 16(5):633-647. 10.1016/j.devcel.2009.03.010, 19460341.
3. Skeldal S, Matusica D, Nykjaer A, Coulson EJ. Proteolytic processing of the p75 neurotrophin receptor: a prerequisite for signalling?: neuronal life, growth and death signalling are crucially regulated by intra-membrane proteolysis and trafficking of p75(NTR). Bioessays 2011, 33(8):614-625. 10.1002/bies.201100036, 21717487.
4. Larios JA, Marzolo MP. Novel aspects of the apolipoprotein-E receptor family: regulation and functional role of their proteolytic processing. Front Biol 2012, 7(2):113-143.
5. Wakabayashi T, De Strooper B. Presenilins: members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda) 2008, 23:194-204. 10.1152/physiol.00009.2008, 18697993.
6. Bronfman FC. Metalloproteases and gamma-secretase: new membrane partners regulating p75 neurotrophin receptor signaling?. J Neurochem 2007, 103(Suppl 1):91-100.
7. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005, 6(8):603-614. 10.1038/nrn1726, 16062169.
8. Campenot RB. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci U S A 1977, 74(10):4516-4519. 10.1073/pnas.74.10.4516, 431975, 270699.
9. Davies AM. Neurotrophins: neurotrophic modulation of neurite growth. Curr Biol 2000, 10(5):R198-R200. 10.1016/S0960-9822(00)00351-1, 10712898.
10. Wright EM, Vogel KS, Davies AM. Neurotrophic factors promote the maturation of developing sensory neurons before they become dependent on these factors for survival. Neuron 1992, 9(1):139-150. 10.1016/0896-6273(92)90229-7, 1321644.
11. Rosch H, Schweigreiter R, Bonhoeffer T, Barde YA, Korte M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc Natl Acad Sci U S A 2005, 102(20):7362-7367. 10.1073/pnas.0502460102, 1129133, 15883381.
12. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996, 16(6):1137-1145. 10.1016/S0896-6273(00)80140-3, 8663990.
13. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006, 361(1473):1545-1564. 10.1098/rstb.2006.1894, 1664664, 16939974.
14. Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991, 65(1):189-197. 10.1016/0092-8674(91)90419-Y, 1849459.
15. Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P, Bryant S, Cordon-Cardo C, Jones KR, Reichardt LF, Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 1991, 66(2):395-403. 10.1016/0092-8674(91)90628-C, 2710095, 1649702.
16. Lamballe F, Klein R, Barbacid M. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 1991, 66(5):967-979. 10.1016/0092-8674(91)90442-2, 1653651.
17. Rodriguez-Tebar A, Dechant G, Barde YA. Neurotrophins: structural relatedness and receptor interactions. Philos Trans R Soc Lond B Biol Sci 1991, 331(1261):255-258. 10.1098/rstb.1991.0013, 1650003.
18. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 1996, 383(6602):716-719. 10.1038/383716a0, 8878481.
19. Hamanoue M, Middleton G, Wyatt S, Jaffray E, Hay RT, Davies AM. p75-mediated NF-kappaB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 1999, 14(1):28-40. 10.1006/mcne.1999.0770, 10433815.
20. Casaccia-Bonnefil P, Gu C, Khursigara G, Chao MV. p75 neurotrophin receptor as a modulator of survival and death decisions. Microsc Res Tech 1999, 45(4-5):217-224.
21. Yamashita T, Tucker KL, Barde YA. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron 1999, 24(3):585-593. 10.1016/S0896-6273(00)81114-9, 10595511.
22. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003, 6(5):461-467.
23. Van der Zee CE, Ross GM, Riopelle RJ, Hagg T. Survival of cholinergic forebrain neurons in developing p75NGFR-deficient mice. Science 1996, 274(5293):1729-1732. 10.1126/science.274.5293.1729, 8939868.
24. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002, 420(6911):74-78. 10.1038/nature01176, 12422217.
25. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002, 5(12):1302-1308. 10.1038/nn975, 12426574.
26. Berg MM, Sternberg DW, Hempstead BL, Chao MV. The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A 1991, 88(16):7106-7110. 10.1073/pnas.88.16.7106, 52242, 1714587.
27. Hantzopoulos PA, Suri C, Glass DJ, Goldfarb MP, Yancopoulos GD. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 1994, 13(1):187-201. 10.1016/0896-6273(94)90469-3, 8043276.
28. Kahle P, Barker PA, Shooter EM, Hertel C. p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells. J Neurosci Res 1994, 38(5):599-606. 10.1002/jnr.490380512, 7815475.
29. Verdi JM, Birren SJ, Ibanez CF, Persson H, Kaplan DR, Benedetti M, Chao MV, Anderson DJ. p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron 1994, 12(4):733-745. 10.1016/0896-6273(94)90327-1, 7512816.
30. Majdan M, Lachance C, Gloster A, Aloyz R, Zeindler C, Bamji S, Bhakar A, Belliveau D, Fawcett J, Miller FD, Barker PA. Transgenic mice expressing the intracellular domain of the p75 neurotrophin receptor undergo neuronal apoptosis. J Neurosci 1997, 17(18):6988-6998.
31. Domeniconi M, Zampieri N, Spencer T, Hilaire M, Mellado W, Chao MV, Filbin MT. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 2005, 46(6):849-855. 10.1016/j.neuron.2005.05.029, 15953414.
32. Kenchappa RS, Zampieri N, Chao MV, Barker PA, Teng HK, Hempstead BL, Carter BD. Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons. Neuron 2006, 50(2):219-232. 10.1016/j.neuron.2006.03.011, 16630834.
33. Srinivasan B, Wang Z, Brun-Zinkernagel AM, Collier RJ, Black RA, Frank SJ, Barker PA, Roque RS. Photic injury promotes cleavage of p75NTR by TACE and nuclear trafficking of the p75 intracellular domain. Mol Cell Neurosci 2007, 36(4):449-461. 10.1016/j.mcn.2007.08.005, 17904861.
34. Coulson EJ, May LM, Osborne SL, Reid K, Underwood CK, Meunier FA, Bartlett PF, Sah P. p75 neurotrophin receptor mediates neuronal cell death by activating GIRK channels through phosphatidylinositol 4,5-bisphosphate. J Neurosci 2008, 28(1):315-324. 10.1523/JNEUROSCI.2699-07.2008, 18171948.
35. Underwood CK, Reid K, May LM, Bartlett PF, Coulson EJ. Palmitoylation of the C-terminal fragment of p75(NTR) regulates death signaling and is required for subsequent cleavage by gamma-secretase. Mol Cell Neurosci 2008, 37(2):346-358. 10.1016/j.mcn.2007.10.005, 18055214.
36. Wang L, Rahn JJ, Lun X, Sun B, Kelly JJ, Weiss S, Robbins SM, Forsyth PA, Senger DL. Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol 2008, 6(11):e289. 10.1371/journal.pbio.0060289, 2586378, 19067488.
37. Ceni C, Kommaddi RP, Thomas R, Vereker E, Liu X, McPherson PS, Ritter B, Barker PA. The p75NTR intracellular domain generated by neurotrophin-induced receptor cleavage potentiates Trk signaling. J Cell Sci 2010, 123(Pt 13):2299-2307.
38. Kenchappa RS, Tep C, Korade Z, Urra S, Bronfman FC, Yoon SO, Carter BD. p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-alpha-converting enzyme/ADAM17. J Biol Chem 2010, 285(26):20358-20368. 10.1074/jbc.M109.082834, 2888447, 20421303.
39. Kommaddi RP, Thomas R, Ceni C, Daigneault K, Barker PA. Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling. FASEB J 2011, 25(6):2061-2070. 10.1096/fj.10-173740, 21411748.
40. Urra S, Escudero CA, Ramos P, Lisbona F, Allende E, Covarrubias P, Parraguez JI, Zampieri N, Chao MV, Annaert W, Bronfman FC. TrkA receptor activation by nerve growth factor induces shedding of the p75 neurotrophin receptor followed by endosomal gamma-secretase-mediated release of the p75 intracellular domain. J Biol Chem 2007, 282(10):7606-7615.
41. Forster E, Bock HH, Herz J, Chai XJ, Frotscher M, Zhao ST. Emerging topics in Reelin function. Eur J Neurosci 2010, 31(9):1511-1518. 2942760, 20525064.
42. Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, Ikenaka K, Yamamoto H, Mikoshiba K. The Reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical-neurons. Neuron 1995, 14(5):899-912. 10.1016/0896-6273(95)90329-1, 7748558.
43. DelRio JA, Heimrich B, Borrell V, Forster E, Drakew A, Alcantara S, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, Derer P, Frotscher M, Soriano E. A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 1997, 385(6611):70-74. 10.1038/385070a0, 8985248.
44. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97(6):689-701. 10.1016/S0092-8674(00)80782-5, 10380922.
45. Drakew A, Deller T, Heimrich B, Gebhardt C, Del Turco D, Tielsch A, Forster E, Herz J, Frotscher M. Dentate granule cells in reeler mutants and VLDLR and ApoER2 knockout mice. Exp Neurol 2002, 176(1):12-24. 10.1006/exnr.2002.7918, 12093079.
46. Gebhardt C, Del Turco D, Drakew A, Tielsch A, Herz J, Frotscher M, Deller T. Abnormal positioning of granule cells alters afferent fiber distribution in the mouse fascia dentata: morphologic evidence from reeler, apolipoprotein E receptor 2-, and very low density lipoprotein receptor knockout mice. J Comp Neurol 2002, 445(3):278-292. 10.1002/cne.10172, 11920707.
47. Beffert U, Durudas A, Weeber EJ, Stolt PC, Giehl KM, Sweatt JD, Hammer RE, Herz J. Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J Neurosci 2006, 26(7):2041-2052. 10.1523/JNEUROSCI.4566-05.2006, 16481437.
48. Beffert U, Weeber EJ, Durudas A, Qiu S, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher M, Hammer RE, Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 2005, 47(4):567-579. 10.1016/j.neuron.2005.07.007, 16102539.
49. Dumanis SB, Cha HJ, Song JM, Trotter JH, Spitzer M, Lee JY, Weeber EJ, Turner RS, Pak DT, Rebeck GW, Hoe HS. ApoE receptor 2 regulates synapse and dendritic spine formation. PLoS One 2011, 6(2):e17203. 10.1371/journal.pone.0017203, 3039666, 21347244.
50. Chai X, Forster E, Zhao S, Bock HH, Frotscher M. Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J Neurosci 2009, 29(1):288-299. 10.1523/JNEUROSCI.2934-08.2009, 19129405.
51. Leemhuis J, Bouche E, Frotscher M, Henle F, Hein L, Herz J, Meyer DK, Pichler M, Roth G, Schwan C, Bock HH. Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation. J Neurosci 2010, 30(44):14759-14772. 10.1523/JNEUROSCI.4036-10.2010, 3523719, 21048135.
52. Beffert U, Nematollah Farsian F, Masiulis I, Hammer RE, Yoon SO, Giehl KM, Herz J. ApoE receptor 2 controls neuronal survival in the adult brain. Curr Biol 2006, 16(24):2446-2452. 10.1016/j.cub.2006.10.029, 17174920.
53. Kysenius K, Muggalla P, Matlik K, Arumae U, Huttunen HJ. PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling. Cell Mol Life Sci 2012, 69(11):1903-1916. 10.1007/s00018-012-0977-6, 22481440.
54. D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 1999, 24(2):471-479. 10.1016/S0896-6273(00)80860-0, 10571240.
55. Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, Hiesberger T, Herz J, Weeber EJ, Sweatt JD, Pramatarova A, Howell B, Schneider WJ, Nimpf J. Receptor clustering is involved in Reelin signaling. Mol Cell Biol 2004, 24(3):1378-1386. 10.1128/MCB.24.3.1378-1386.2004, 321426, 14729980.
56. Morimura T, Hattori M, Ogawa M, Mikoshiba K. Disabled1 regulates the intracellular trafficking of reelin receptors. J Biol Chem 2005, 280(17):16901-16908. 10.1074/jbc.M409048200, 15718228.
57. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24(2):481-489. 10.1016/S0896-6273(00)80861-2, 10571241.
58. Howell BW, Herrick TM, Cooper JA. Reelin-induced tyrosine [corrected] phosphorylation of disabled 1 during neuronal positioning. Genes Dev 1999, 13(6):643-648. 10.1101/gad.13.6.643, 316552, 10090720.
59. Bock HH, Herz J. Reelin activates SRC family tyrosine kinases in neurons. Curr Biol 2003, 13(1):18-26. 10.1016/S0960-9822(02)01403-3, 12526740.
60. Bock HH, Jossin Y, Liu P, Forster E, May P, Goffinet AM, Herz J. Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J Biol Chem 2003, 278(40):38772-38779. 10.1074/jbc.M306416200, 12882964.
61. Chai X, Forster E, Zhao S, Bock HH, Frotscher M. Reelin acts as a stop signal for radially migrating neurons by inducing phosphorylation of n-cofilin at the leading edge. Commun Integr Biol 2009, 2(4):375-377. 10.4161/cib.2.4.8614, 2734053, 19721896.
62. Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J. Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J Biol Chem 2002, 277(51):49958-49964. 10.1074/jbc.M209205200, 12376533.
63. Duit S, Mayer H, Blake SM, Schneider WJ, Nimpf J. Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors. J Biol Chem 2010, 285(7):4896-4908. 10.1074/jbc.M109.025973, 2836094, 19948739.
64. Hoe HS, Rebeck GW. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res Mol Brain Res 2005, 137(1-2):31-39.
65. Hoe HS, Wessner D, Beffert U, Becker AG, Matsuoka Y, Rebeck GW. F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein. Mol Cell Biol 2005, 25(21):9259-9268. 10.1128/MCB.25.21.9259-9268.2005, 1265841, 16227578.
66. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007, 20(6):687-702. 10.1159/000110430, 17982252.
67. Shi Y, Mantuano E, Inoue G, Campana WM, Gonias SL. Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway. Sci Signal 2009, 2(68):ra18. 2696635, 19401592.
68. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 1976, 73(7):2424-2428. 10.1073/pnas.73.7.2424, 430592, 1065897.
69. Greene LA. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol 1978, 78(3):747-755. 10.1083/jcb.78.3.747, 2110184, 701359.
70. Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G. Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 2004, 41(1):71-84. 10.1016/S0896-6273(03)00819-5, 14715136.
71. Sotelo P, Farfan P, Benitez ML, Bu G, Marzolo MP. Sorting Nexin 17 Regulates ApoER2 Recycling and Reelin Signaling. PLoS One 2014, 9(4):e93672. 10.1371/journal.pone.0093672, 3976305, 24705369.
72. Weskamp G, Schlondorff J, Lum L, Becherer JD, Kim TW, Saftig P, Hartmann D, Murphy G, Blobel CP. Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J Biol Chem 2004, 279(6):4241-4249.
73. Hoe HS, Cooper MJ, Burns MP, Lewis PA, van der Brug M, Chakraborty G, Cartagena CM, Pak DT, Cookson MR, Rebeck GW. The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J Neurosci 2007, 27(40):10895-10905. 10.1523/JNEUROSCI.3135-07.2007, 17913923.
74. Ohkubo N, Vitek MP, Morishima A, Suzuki Y, Miki T, Maeda N, Mitsuda N. Reelin signals survival through Src-family kinases that inactivate BAD activity. J Neurochem 2007, 103(2):820-830. 10.1111/j.1471-4159.2007.04804.x, 17696989.
75. Kong DX, Yamori T. ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system. Acta Pharmacol Sin 2010, 31(9):1189-1197. 10.1038/aps.2010.150, 4002321, 20729870.
76. Carpentier S, N'Kuli F, Grieco G, Van Der Smissen P, Janssens V, Emonard H, Bilanges B, Vanhaesebroeck B, Gaide Chevronnay HP, Pierreux CE, Tyteca D, Courtoy PJ. Class III phosphoinositide 3-kinase/VPS34 and dynamin are critical for apical endocytic recycling. Traffic 2013, 14(8):933-948. 10.1111/tra.12079, 23621784.
77. Barr AM, Fish KN, Markou A. The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. Neuropharmacology 2007, 52(4):1114-1123. 10.1016/j.neuropharm.2006.11.011, 1861840, 17261317.
78. D'Arcangelo G. Apoer2: a reelin receptor to remember. Neuron 2005, 47(4):471-473. 10.1016/j.neuron.2005.08.001, 16102527.
79. Soond SM, Everson B, Riches DW, Murphy G. ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 2005, 118(Pt 11):2371-2380.
80. Xu P, Liu J, Sakaki-Yumoto M, Derynck R. TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association. Sci Signal 2012, 5(222):ra34. 10.1126/scisignal.2002689, 22550340.
81. Van Schaeybroeck S, Kyula JN, Fenton A, Fenning CS, Sasazuki T, Shirasawa S, Longley DB, Johnston PG. Oncogenic Kras promotes chemotherapy-induced growth factor shedding via ADAM17. Cancer Res 2011, 71(3):1071-1080. 10.1158/0008-5472.CAN-10-0714, 3073126, 21148749.
82. Gruenberg J. Lipids in endocytic membrane transport and sorting. Curr Opin Cell Biol 2003, 15(4):382-388. 10.1016/S0955-0674(03)00078-4, 12892777.
83. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006, 443(7112):651-657. 10.1038/nature05185, 17035995.
84. Spiro DJ, Boll W, Kirchhausen T, Wessling-Resnick M. Wortmannin alters the transferrin receptor endocytic pathway in vivo and in vitro. Mol Biol Cell 1996, 7(3):355-367. 10.1091/mbc.7.3.355, 275889, 8868465.
85. Brabec M, Blaas D, Fuchs R. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments. Biochem Biophys Res Commun 2006, 348(2):741-749. 10.1016/j.bbrc.2006.07.125, 16890915.
86. Hill RA, Wu YW, Gogos A, van den Buuse M. Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones. J Neurochem 2013, 126(3):389-399. 10.1111/jnc.12205, 23414458.
87. Ringstedt T, Linnarsson S, Wagner J, Lendahl U, Kokaia Z, Arenas E, Ernfors P, Ibanez CF. BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron 1998, 21(2):305-315. 10.1016/S0896-6273(00)80540-1, 9728912.
88. Do HT, Bruelle C, Tselykh T, Jalonen P, Korhonen L, Lindholm D. Reciprocal regulation of very low density lipoprotein receptors (VLDLRs) in neurons by brain-derived neurotrophic factor (BDNF) and Reelin: involvement of the E3 ligase Mylip/Idol. J Biol Chem 2013, 288(41):29613-29620. 10.1074/jbc.M113.500967, 23990472.
89. Pillai A, Mahadik SP. Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophr Res 2008, 100(1-3):325-333.
90. Balmaceda V, Cuchillo-Ibanez I, Pujadas L, Garcia-Ayllon MS, Saura CA, Nimpf J, Soriano E, Saez-Valero J. ApoER2 processing by presenilin-1 modulates reelin expression. FASEB J 2014, 28(4):1543-1554. 10.1096/fj.13-239350, 24344333.
91. Nieto R, Kukuljan M, Silva H. BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory. Front Psychiatr 2013, 4:45.
92. Eisenberg DP, Ianni AM, Wei SM, Kohn PD, Kolachana B, Apud J, Weinberger DR, Berman KF. Hippocampal dysfunction in schizophrenia: association with brain-derived neurotrophic factor genotype. Mol Psychiatry 2013, 18(6):631. 10.1038/mp.2013.53, 23698315.
93. Fatemi SH. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol Psychiatry 2001, 6(2):129-133. 10.1038/sj.mp.4000129, 11317213.
94. Fatemi SH. Reelin glycoprotein in autism and schizophrenia. Int Rev Neurobiol 2005, 71:179-187.
95. Iafrati J, Orejarena MJ, Lassalle O, Bouamrane L, Chavis P. Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol Psychiatry 2014, 19(4):417-426. 10.1038/mp.2013.66, 3965840, 23752244.
96. Das UN. Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition 2013, 29(10):1175-1185. 10.1016/j.nut.2013.01.012, 23911220.
97. Abdallah MW, Mortensen EL, Greaves-Lord K, Larsen N, Bonefeld-Jorgensen EC, Norgaard-Pedersen B, Hougaard DM, Grove J. Neonatal levels of neurotrophic factors and risk of autism spectrum disorders. Acta Psychiatr Scand 2013, 128(1):61-69. 10.1111/acps.12020, 23039165.
98. Sheikh AM, Malik M, Wen G, Chauhan A, Chauhan V, Gong CX, Liu F, Brown WT, Li X. BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res 2010, 88(12):2641-2647.
99. Koch S, Strasser V, Hauser C, Fasching D, Brandes C, Bajari TM, Schneider WJ, Nimpf J. A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling. EMBO J 2002, 21(22):5996-6004. 10.1093/emboj/cdf599, 137191, 12426372.
100. May P, Bock HH, Nimpf J, Herz J. Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. J Biol Chem 2003, 278(39):37386-37392. 10.1074/jbc.M305858200, 12871934.
101. Fuentealba RA, Barria MI, Lee J, Cam J, Araya C, Escudero CA, Inestrosa NC, Bronfman FC, Bu G, Marzolo MP. ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity. Mol Neurodegener 2007, 2:14. 10.1186/1750-1326-2-14, 1939850, 17620134.
102. Cuitino L, Matute R, Retamal C, Bu G, Inestrosa NC, Marzolo MP. ApoER2 is endocytosed by a clathrin-mediated process involving the adaptor protein Dab2 independent of its Rafts' association. Traffic 2005, 6(9):820-838. 10.1111/j.1600-0854.2005.00320.x, 16101684.